Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix

Bone

Volumn 49, Issue 3, 2011, Pages 368-375

  Okamura, Hirohiko ^a   Yoshida, Kaya ^a   Ochiai, Kazuhiko ^a   Haneji, Tatsuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bone formation; Differentiation; Osteoblasts; Osterix; Protein phosphatase 2A

Indexed keywords

BONE SIALOPROTEIN; OKADAIC ACID; OSTEOCALCIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE 2A CALPHA; TRANSCRIPTION FACTOR OSTERIX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE STRUCTURE; BONE THICKNESS; CALVARIA; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IN VIVO STUDY; MORPHOMETRICS; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOBLAST; PROTEIN EXPRESSION; UPREGULATION;

3T3 CELLS; ANIMALS; BONE DENSITY; CELL DIFFERENTIATION; ENZYME INHIBITORS; GENE KNOCKDOWN TECHNIQUES; INTEGRIN-BINDING SIALOPROTEIN; MICE; MICE, INBRED BALB C; OKADAIC ACID; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PROTEIN PHOSPHATASE 2; SKULL; TRANSCRIPTION FACTORS;

EID: 79960585241     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.004     Document Type: Article

References (32)

1. Wang B., Zhang P., Wei Q. Recent progress on the structure of Ser/Thr protein phosphatases. Sci China C Life Sci 2008, 51:487-494.
2. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell 2009, 139:468-484.
3. Shi Y. Assembly and structure of protein phosphatase 2A. Sci China C Life Sci 2009, 52:135-146.
4. Westermarck J., Hahn W.C. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 2008, 14:152-160.
5. Janssens V., Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 2001, 353:417-439.
6. Götz J., Probst A., Ehler E., Hemmings B., Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα. Proc Natl Acad Sci U S A 1998, 95:12370-12375.
7. Götz J., Probst A., Mistl C., Nitsch R.M., Ehler E. Distinct role of protein phosphatase 2A subunit Cα in the regulation of E-cadherin and α-catenin during development. Mech Dev 2000, 93:83-93.
8. Götz J., Schild A. Transgenic and knockout models of PP2A. Methods Enzymol 2003, 366:390-403.
9. Murata T., Shirakawa S., Takehara T., Kobayashi S., Haneji T. Protein phosphatase inhibitors, okadaic acid and calyculin A, induce alkaline phosphatase activity in osteoblastic cells derived from newborn mouse calvaria. Biochem Mol Biol Int 1995, 36:365-372.
10. Goad D.L., Meurer E.A., Voelkel E.F., Petrou C.P., Tashjian A.H. Protein phosphatase inhibitors and bone resorption: inhibition by okadaic acid and biphasic actions of calyculin A. Endocrinology 1992, 130:3402-3410.
11. Kaback L.A., Soung D.Y., Naik A., Smith N., Schwarz E.M., O'Keefe R.J., et al. Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification. J Cell Physiol 2008, 214:173-182.
12. Amorim B.R., Okamura H., Yoshida K., Qiu L., Morimoto H., Haneji T. The transcription factor Osterix directly interacts with RNA helicase A. Biochem Biophys Res Commun 2007, 355:347-351.
13. Okamura H., Amorim B.R., Wang J., Yoshida K., Haneji T. Biochem Biophys Res Commun 2009, 379:440-444.
14. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
15. Karsenty G., Wagner E.F. Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2002, 2:389-406.
16. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006, 99:1233-1239.
17. Marie P.J. Transcription factors controlling osteoblastgenesis. Arch Biochem Biophys 2008, 473:98-105.
18. Tai G., Polak J.M., Bishop A.E., Christodoulou I., Buttery L.D.K. Differentiation of osteoblasts from murine embryonic stem cells by overexpression of the transcription factor osterix. Tissue Eng 2004, 10:1456-1466.
19. Yoshida K., Okamura H., Amorim B.R., Ozaki A., Tanaka H., Morimoto H., et al. Double-stranded RNA-dependent protein kinase is required for bone calcification in MC3T3-E1 cells in vitro. Exp Cell Res 2005, 311:117-125.
20. Ishihara H., Martin B.L., Brautigan D.L., Karaki H., Ozaki H., Kato Y., et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 1989, 159:871-877.
21. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Biochem J 1998, 256:283-290.
22. Morimoto H., Okamura H., Yoshida K., Kitamura S., Haneji T. Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2α pathway in human osteoblastic MG63 cells. J Biochem 2004, 136:433-438.
23. Fujita M., Goto K., Yoshida K., Okamura H., Morimoto H., Kito S., et al. Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells. Oral Oncol 2004, 40:199-206.
24. Okamura H., Yoshida K., Morimoto H., Haneji T. PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells. J Cell Biochem 2005, 94:117-125.
25. Yeo H., Beck L.H., McDonald J.M., Zayzafoon M. Cyclosporin A elicits dose-dependent biphasic effects on osteoblast differentiation and bone formation. Bone 2007, 40:1502-1516.
26. Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 2008, 9:183-189.
27. Baek W.Y., de Crombrugghe B., Kim J.E. Postnatally induced inactivation of Osterix in osteoblasts results in the reduction of bone formation and maintenance. Bone 2010, 46:920-928.
28. Ortuño M.J., Ruiz-Gaspá S., Rodríguez-Carballo E., Susperregui A.R.G., Bartrons R., Rosa J.L., et al. p38 regulates expression of osteoblast-specific genes by phosphorylation of Osterix. J Biol Chem 2010, 285:31985-31994.
29. Gordon J.A.R., Tye C., Sampaio A.V., Underhill T.M., Hunter G.K., Goldberg H.A. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007, 41:462-473.
30. Ulsamer A., Ortuño M.J., Ruiz-Gaspá S., Susperregui A.R.G., Osses N., Rosa J.L., et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J Biol Chem 2008, 283:3816-3826.
31. Celil A.B., Campbell P.G. Osx transcriptional regulation is mediated by additional pathways to BMP/Smad signaling. J Cell Biochem 2005, 95:518-8.
32. Celil A.B., Campbell P.G. BMP-2 and insulin-like growth factor-I mediate osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 2005, 280:31353-31359.